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Abstract
Background: An inverse relationship between solar ultraviolet-B (UV-B) exposure and non-skin
cancer mortality has long been reported. Vitamin D, acquired primarily through exposure to the
sun via the skin, is believed to inhibit tumor development and growth and reduce mortality for
certain cancers.
Methods: We extend the analysis of this relationship to include cancer incidence as well as
mortality, using higher quality and higher resolution data sets than have typically been available.
Over three million incident cancer cases between 1998 and 2002 and three million cancer deaths
between 1993 and 2002 in the continental United States were regressed against daily satellite-
measured solar UV-B levels, adjusting for numerous confounders. Relative risks of reduced solar
UV-B exposure were calculated for thirty-two different cancer sites.
Results: For non-Hispanic whites, an inverse relationship between solar UV-B exposure and
cancer incidence and mortality was observed for ten sites: bladder, colon, Hodgkin lymphoma,
myeloma, other biliary, prostate, rectum, stomach, uterus, and vulva. Weaker evidence of an
inverse relationship was observed for six sites: breast, kidney, leukemia, non-Hodgkin lymphoma,
pancreas, and small intestine. For three sites, inverse relationships were seen that varied markedly
by sex: esophagus (stronger in males than females), gallbladder (stronger in females than males),
and thyroid (only seen in females). No association was found for bone and joint, brain, larynx, liver,
nasal cavity, ovary, soft tissue, male thyroid, and miscellaneous cancers. A positive association
between solar UV-B exposure and cancer mortality and incidence was found for anus, cervix, oral
cavity, melanoma, and other non-epithelial skin cancer.
Conclusion: This paper adds to the mounting evidence for the influential role of solar UV-B
exposure on cancer, particularly for some of the less-well studied digestive cancers. The relative
risks for cancer incidence are similar to those for cancer mortality for most sites. For several sites
(breast, colon, rectum, esophagus, other biliary, vulva), the relative risks of mortality are higher,
possibly suggesting that the maintenance of adequate vitamin D levels is more critical for limiting
tumor progression than for preventing tumor onset. Our findings are generally consistent with the
published literature, and include three cancer sites not previously linked with solar UV-B exposure,
to our knowledge: leukemia, small intestine, and vulva.
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Background
A wide range of experimental evidence suggests that vita-
min D has benefits against a variety of cancer types [1-3].
The primary source of vitamin D for most people in tem-
perate climates, particularly people with light-colored
skin, is solar ultraviolet-B exposure [4,5], and the amount
of exposure to the sun has been found to correlate
inversely with cancer mortality and survival in numerous
epidemiological studies. Indeed, this observation has
been noted at least since the 1930s [6]. The inverse rela-
tionship holds whether long-term cumulative exposure or
short-term seasonal exposure is considered [7]. Among
the cancer sites for which this inverse relationship has
been repeatedly found are prostate [8-16], female breast
[8,12,13,15,17-19], and colon and rectum
[8,12,13,15,20-23]. Findings have also been reported for
ovary [8,13,15,24], uterus [13], bladder [13,15], esopha-
gus [13,15,21], kidney [13,15], lung [13,25], pancreas
[13,15,21], stomach [13,15,21], gallbladder and bile duct
[15,21], larynx [15], cervix [15], and Hodgkin lymphoma
[15,26]. Non-Hodgkin lymphoma has been hypothesized
both to be inversely and positively associated with solar
UV-B exposure, with the positive hypothesis based on an
observed comorbidity with certain skin cancers [27].
Study results exist in support of both hypotheses, though
more recent studies favor the inverse association [15,28-
33]. For an exhaustive literature review see [2].
Most of the above studies have relied on mortality data
exclusively. In this paper, we use both incidence and mor-
tality data, as well as more precise (albeit ecologic) expo-
sure measures and adjustments for confounding variables
than has been typical. We calculate age-specific relative
risks for incidence and mortality for 32 different cancer
sites using data sets of over three million incident cancer
cases (1998–2002) and three million cancer deaths
(1993–2002) among white non-Hispanics and blacks in
the continental United States, after adjusting for socioeco-
nomic, behavioral, occupational, environmental, and
geographic risk factors.
Methods
Cancer incidence and mortality were measured at the
county level, using incidence data from the North Ameri-
can Association of Central Cancer Registries' CINA Deluxe
file [34] and mortality data from the National Cancer
Institute's SEER*Stat database [35]. The data consist of
approximately 3.1 million incident cancer cases and 3.1
million cancer deaths among white non-Hispanics and
300,000 incident cancer cases and 400,000 cancer deaths
among blacks for thirty-two cancer sites (Blacks, with lim-
ited sensitivity to geographic variation in solar exposure,
serve as a useful comparison group). The included cancer
sites were those with at least four thousand incident cases
and four thousand deaths, excepting lung cancer as it was
used as the basis for adjusting for smoking [36]. Data were
stratified by sex, race/ethnicity and ten-year age groups
from 35–44 through 85+. For mortality, data were availa-
ble for 3,108 counties in all states except Hawaii and
Alaska, plus the District of Columbia. For incidence, data
were available for 1,499 counties in all or parts of 32 states
plus the District of Columbia, incorporating about 65%
of the United States population (Figure 1). Areas were
excluded where county-specific data was unavailable.
Solar UV-B exposure was measured using data from
NASA's Total Ozone Mapping Spectrometer (TOMS) [37].
This device has been installed on several spacecraft,
including the Earth Probe spacecraft for data from 1996 to
2005. The data consist of an ongoing time series of ery-
themally-weighted UV-B exposure values for the entire
globe, derived from directly-measured noon irradiance
values which take into account length of day, cloud con-
ditions, and ozone column. The erythemally-weighted
average exposure is the combination of wavelengths from
280–400 nm that best describes the susceptibility of Cau-
casian skin to sunburn [38]. The shorter wavelengths are
the most dangerous, but are blocked by the atmosphere to
a greater extent; the result is that in the continental United
States about 85% of the contribution to the erythemally
weighted average comes from the 300–320 nm range [39].
The wavelengths most important for causing sunburn are
similar to those involved in vitamin D production [40].
Solar UV-B exposure was based on measurements
between September 1, 1996 and August 31, 2003 (seven
complete years), at a geographic resolution of one degree.
A degree is about 111 kilometers north to south and
between 75 and 101 kilometers east to west in the conti-
nental United States, depending on latitude. Each meas-
urement location had measurements for between 88%
and 97% of the days, with most of the missing values due
to the orbital path of the satellite. For each location, we
grouped the daily measurements by month in order to cal-
culate monthly averages; the average annual exposure was
calculated as the sum of the twelve monthly averages.
Exposure values for individual counties were then
obtained through areal interpolation using GIS software,
resulting in the exposure map seen in Figure 2. As indi-
cated by the figure, exposure correlates closely with lati-
tude, with greater exposure at higher elevations and
greater variability in exposure in areas of high relief.
Poisson regression modeling was performed using PROC
GENMOD in SAS version 9.1 (SAS Institute, Cary, NC).
Poisson regression is a special case of the Generalized Lin-
ear Model where the response variable is a count, as is true
for cancer cases. The model included ecologic adjustment
for the demographic, behavioral and environmental risk
factors listed in Table 1. For each cancer site/sex/age/raceBMC Cancer 2006, 6:264 http://www.biomedcentral.com/1471-2407/6/264
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combination, the relative risk of residing along the north-
ern border of the continental United States (e.g., northern
Maine, Minnesota or Washington state) versus the south-
ern border (e.g., southern Florida, Texas or Arizona) was
calculated. Specifically, the relative risk corresponding to
an exposure of 650 kJ/m2-year versus 1540 kJ/m2-year was
calculated. This is a convenient way of reporting the vari-
ation of risk across the continental United States. Pre-
dicted relative risks for intermediate locations in the
country can be calculated proportionally. For example,
the relative risk in North Carolina, Tennessee, and Arkan-
sas, where the exposure is about 1100 kJ/m2-year versus
the southern border, would be half of that reported for the
northern border.
The migration of retirees to the southern United States
could be expected to bias results toward the null, because
exposure levels there would be overstated. To address this
issue, the analysis was repeated after excluding counties
with high rates of migration from places with very differ-
ent solar exposures. The 2000 census county-to-county
migration flow file identifies the number of people who
moved from and to each county between 1995 and 2000
[41]. Counties were excluded from the analysis if more
than one-fifth of the population moved from an area with
an average annual exposure that was different by more
than 100 kJ/m2-year. This resulted in the exclusion of 6
counties in the incidence analysis and 38 counties in the
mortality analysis, representing less than 1% of the cases
in each analysis. The excluded counties were primarily in
the southern and western United States, particularly in
Colorado and Florida.
Results
The relative risks of cancer incidence and mortality for res-
idence along the northern versus southern United States
boundary for 32 cancer sites are shown in Tables 2
through 5, grouped into four categories based on their
level of association. The categorization took into account
magnitude of risk, confidence intervals, consistency
between incidence and mortality, and separately calcu-
lated age-specific relative risks (not shown). Ten sites
showed strong evidence of an inverse association with
solar UV-B exposure: bladder, colon, Hodgkin lym-
phoma, myeloma, other biliary, prostate, rectum, stom-
ach, uterus, and vulva, with two other sites showing this
relationship for only one sex (male esophagus, female
gallbladder) (Table 2). Weaker evidence of an association
States and counties with available incidence data Figure 1
States and counties with available incidence data.
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was seen for six sites (female breast, kidney, leukemia,
non-Hodgkin lymphoma, pancreas, and small intestine),
as well as for female esophagus, male gallbladder, and
female thyroid (Table 3). No evidence of a relationship
was seen for eight sites (bone and joint, brain, larynx,
liver, miscellaneous sites, nasal cavity, ovary, soft tissue)
as well as male thyroid (Table 4). Solar UV-B exposure was
positively associated with five sites of cancer (anus, cervix,
melanoma, oral cavity, and other skin) (Table 5).
The largest effects were seen for female gallbladder cancer,
with nearly a doubling of risk of both incidence and mor-
tality; uterine cancer, with about a 50% elevated risk; and
stomach cancer, with about a 30% elevated risk. Where
incidence and mortality risks differed substantially, the
higher risk tended to be for mortality, as seen for colon,
rectum, other biliary, vulva, breast, esophagus, and mis-
cellaneous sites. One exception was bone and joint can-
cers, where the risk of incidence is independent of solar
UV-B exposure, but the risk of mortality was substantially
lower in the south.
For blacks, there was some evidence of association with
solar UV-B exposure, but with great inconsistency
between sexes and between incidence and mortality for
given sites (data not shown). The only site with elevated
relative risks for living in the northern versus southern
United States that were consistent for both males and
females, for both incidence and mortality, was esophagus,
with relative risks in the 1.3 to 1.5 range. Evidence of a
north-south gradient was also seen for bladder, colon,
kidney, larynx, myeloma, and pancreas for female only,
and for liver in males only. Female breast cancer was also
higher in the north than in the south among blacks, with
relative risks of 1.15 (95% confidence interval, 1.11–
1.19) for incidence and 1.11 (1.06–1.16) for mortality.
While these results overlap those found by Grant in a
study focused on blacks [42], it is possible that factors
other than vitamin D may be required to explain these dif-
ferences. Part of the difficulty in interpreting the results for
blacks arises from the much smaller number of cases,
leading to less certain estimates.
The deletion of cases from high-migration areas had little
impact on the results. This remained true even after low-
Annual erythemally-weighted ultraviolet-B exposure, kJ/m2 Figure 2
Annual erythemally-weighted ultraviolet-B exposure, kJ/m2.
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ering the migrant population threshold from 20% to
10%, resulting in the exclusion of many more counties
(data not shown). Generally, the relative risks of living in
the northern versus southern United States were slightly
more pronounced when high-migration areas were
excluded, as expected. The site with the greatest sensitivity
to this variable was gallbladder, which has high mortality
rates in the Southwest independent of sun exposure; when
some counties in Arizona and New Mexico were excluded,
its association with sun exposure increased.
Discussion
In a recent review article, Giovannucci presents the bio-
logical plausibility of the vitamin D hypothesis [1]. Ultra-
violet radiation from sunlight produces vitamin D in the
skin, which is then hydroxylated in the liver to produce
25(OH)D. Many cell types, including some cancerous cell
types, are able to convert 25(OH)D into the more active
form of 1,25(OH)2D by 1-α-hydroxylase. This function is
also performed by the kidneys. Circulating vitamin D acti-
vates vitamin D receptors that are located on many cells
[43], including cancerous cells, arresting tumor progres-
sion and metastasis. The variable efficacy of the vitamin D
conversion function by different organs and cell types
may account for some of the variation in risk seen
between different cancer sites.
For individual cancer sites, the relative incidence risk and
relative mortality risk tended to be similar. Among sites
with strong evidence of an inverse association with solar
UV-B exposure, there was a higher relative mortality risk
for breast, colon, rectum, esophagus, other biliary, and
vulva. These differences could possibly be related to
regional differences in screening, treatment and medical
utilization practices; for this reason, incidence data are
generally considered preferable to mortality data. But this
would imply that there was something about the medical
care infrastructure of northern states that was inferior to
that of southern states. Recalling that a wide range of fac-
tors have been adjusted for in the model, this hypothesis
does not make much sense. If anything, the greater con-
centration of established research hospitals in the older
cities in the northern half of the country would be
expected to produce an effect opposite the one seen. Even
if important regional differences in the medical care infra-
structure did exist, there is no reason to expect them to
vary latitudinally in the same manner as solar UV-B levels.
A more plausible hypothesis is that the differences
between incidence and mortality are related to solar UV-B
exposure. Several recent studies that focused on the time
of diagnosis and death concluded that vitamin D levels
are more relevant to disease progression than disease
onset [7,12]. In these studies, little or no pattern was seen
in the season of diagnosis (except for a reduction during
major holidays, when the level of non-emergency care is
reduced), but a strong association was found with the sea-
son of death, with death rates higher in winter months
when circulating vitamin D levels are at a minimum. Thus
it may be that one's overall risk of contracting colon can-
cer may be moderately influenced by reduced solar UV-B
exposure (with an increased risk of 10% to 15% in the
northern versus southern United States), while the risk of
dying from the disease is more strongly related to reduced
solar UV-B exposure (with an increased risk of 25% to
30%).
Incomplete control of confounding may have influenced
our findings. For example, there may exist regional varia-
tions in viruses and organisms that are believed to be
Table 1: Confounding variables adjusted for in the model.
Variable Definition Source Geographic Level Sex-specific Race-specific
Age 10-year age groups from 35–44 to 75–84, and 
85+
SEER County X X
Poverty % of households below poverty rate 2000 US Census County X X
Income Median household income in dollars 2000 US Census County X
Smoking Age-adjusted lung and bronchus cancer 
mortality rate
SEER County X X
Exercise % with no exercise in last 30 days BRFSS 1994–2002 
(even years) & 2001
State X X
Alcohol Average number of drinks in past 30 days BRFSS 1997, 1999, 
2001, 2002
State X X
Outdoor occupation % of workers in agriculture, forestry, fishing, 
hunting, or construction
2000 US Census County X
Urban/rural % rural population Average annual PM2.5 
concentrationa
2000 US Census County
Air quality (values for ~ 600 counties known, remainder 
were interpolated)
US EPA AirNow 
database 2000
County
a Particulate matter results in an overestimation of surface-level ultraviolet exposure indicated by the TOMS data, since particulate matter absorbs 
ultraviolet radiation [46]BMC Cancer 2006, 6:264 http://www.biomedcentral.com/1471-2407/6/264
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linked with cancer, such as hepatitis B and C infection and
aflatoxin for liver cancer, and HPV infection for cervix,
vulva, and anal cancer. The enormous racial grouping
"white" also may be problematic, insofar as there exist
important regional ethnic variations within the grouping
as well as geographically variable degrees of racial mixing
or miscoding. For example, the high gallbladder cancer
mortality rates among whites in the Southwest, which
would not be expected under the vitamin D hypothesis,
probably reflect the influence of Hispanics and American
Indians, who have much higher rates of this disease [44].
Smokeless tobacco use, which is a leading risk factor for
oral cancer and strongly concentrated in the rural South,
was not adjusted for at all because of insufficient data.
Regional variation in diet may have also influenced the
findings, particularly for the digestive cancers, although
Grant [13] and others argue against this.
Systematic coding problems for several of the cancer sites
likely influenced the results. Many advanced cancers
metastasize to the bone, so that the geographic pattern of
bone and joint cancer mortality, for example, may be
influenced by geographically differential misclassification
of metastatic tumors as primary tumors. The existence of
such misclassification is strongly suggested by sharp dif-
ferences in rates of miscellaneous cancers between adja-
cent states [45] (Miscellaneous cancer is a catch-all
category incorporating ambiguous, vague or ill-defined
sites such as "abdomen" or "thorax", along with unknown
sites). Both the tendency to classify cases ambiguously
and the tendency to misclassify metastatic tumors are
Table 2: Relative risk of incidence and mortalitya related to solar UV-B exposure, northern versus southern United States boundaryb, 
non-Hispanic whites (95% CI in parentheses): Cancer sites with strongest evidence of an inverse association with solar UV-B exposure.
Incidence Mortality
Cancer site Males Females Males Females
Esophagus (males) 1.27 (1.21–1.34) 1.36 (1.31–1.41)
Stomach 1.42 (1.35–1.49) 1.27 (1.19–1.36) 1.31 (1.26–1.36) 1.26 (1.21–1.32)
Colon 1.11 (1.08–1.13) 1.14 (1.11–1.16) 1.27 (1.24–1.30) 1.24 (1.22–1.27)
Rectum 1.27 (1.23–1.32) 1.14 (1.09–1.18) 1.53 (1.45–1.60) 1.37 (1.30–1.44)
Gallbladder (females) 1.86 (1.66–2.09) 1.98 (1.82–2.16)
Other biliary 1.20 (1.07–1.35) 1.21 (1.07–1.36) 1.56 (1.40–1.75) 1.58 (1.43–1.76)
Uterus 1.49 (1.45–1.53) 1.52 (1.46–1.58)
Vulva 1.18 (1.09–1.29) 1.93 (1.72–2.17)
Prostate 1.20 (1.19–1.22) 1.17 (1.15–1.19)
Bladder 1.13 (1.10–1.16) 1.15 (1.11–1.20) 1.24 (1.20–1.28) 1.21 (1.15–1.27)
Hodgkin lymphoma 1.16 (1.04–1.29) 1.19 (1.05–1.34) 1.14 (1.00–1.30) 1.25 (1.09–1.43)
Myeloma 1.19 (1.12–1.27) 1.22 (1.14–1.31) 1.16 (1.11–1.22) 1.16 (1.11–1.21)
aAdjusted for the variables listed in Table 1 and excluding high-migration counties. Incidence includes states and counties shown in Figure 1 for the 
period 1998–2002 ; mortality includes entire United States except Alaska and Hawaii for the period 1993–2002.
b Relative risk of receiving annual average of 650 kJ/m2 of erythemally-weighted ultraviolet exposure (a value typical of northern Maine, Minnesota 
or Washington) versus annual average of 1540 kJ/m2 (a value typical of southern Florida, Texas, or Arizona).
Table 3: Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, 
non-Hispanic whites (95% CI in parentheses): Cancer sites with weaker evidence of an inverse association with UV-B exposure (see 
notes for Table 2).
Incidence Mortality
Cancer site Males Females Males Females
Esophagus (females) 1.08 (0.99–1.19) 1.21 (1.14–1.28)
Small intestine 1.15 (1.03–1.28) 1.20 (1.07–1.35) 1.07 (0.93–1.22) 1.24 (1.08–1.42)
Gallbladder (males) 1.13 (0.94–1.35) 1.58 (1.38–1.82)
Pancreas 1.09 (1.05–1.14) 1.17 (1.13–1.22) 1.06 (1.03–1.09) 1.11 (1.08–1.14)
Breast 1.06 (1.05–1.07) 1.15 (1.13–1.17)
Kidney 1.09 (1.05–1.13) 1.17 (1.11–1.22) 1.12 (1.08–1.17) 1.20 (1.14–1.25)
Thyroid (females) 1.10 (1.05–1.16) 1.30 (1.16–1.47)
Non-Hodgkin lymphoma 1.08 (1.05–1.12) 1.09 (1.05–1.12) 1.12 (1.08–1.15) 1.15 (1.12–1.18)
Leukemia 1.09 (1.04–1.13) 1.15 (1.10–1.20) 1.07 (1.03–1.10) 1.09 (1.06–1.13)BMC Cancer 2006, 6:264 http://www.biomedcentral.com/1471-2407/6/264
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related to resource issues at both the state and hospital
levels.
Finally, this being an ecologic study, all of the usual limi-
tations of an ecologic study apply. The ecologic adjust-
ments that were made for smoking, outdoor occupation,
particulate matter, and so on were not optimal, relying on
proxy measures, survey data, spatial interpolations and
other imperfect instruments. The central premise of the
study – that where you live determines your sun exposure
– while reasonable, is subject to many possible local
exceptions, and no data are available that distinguish the
solar exposure levels of those with cancer to those without
cancer in a given location.
Conclusion
This paper represents the first effort to relate cancer inci-
dence and solar UV-B exposure on a population basis, to
our knowledge. In so doing, we have also corroborated
much of the previous research on the relationship
between solar UV-B exposure and cancer mortality. We
found at least some evidence of an inverse association for
nineteen cancer sites and no evidence of an association for
eight sites. Five other sites were found to be positively
associated with solar UV-B. We are unaware of any previ-
ous reports citing leukemia, small intestine, or vulva as
being associated with solar UV-B, and only limited (in
some cases single) reports identifying bladder, esophagus,
gallbladder, Hodgkin's lymphoma, kidney, myeloma,
stomach, other biliary, and uterus. We failed to corrobo-
rate previous reports linking laryngeal and cervical cancer
to reduced solar UV-B exposure; we found no relationship
for larynx and found that cervical cancer was positively
associated with solar UV-B.
By using both incidence and mortality data, large sample
sizes, county-level geographic resolution, high-resolution
solar exposure data, and adjustment for numerous con-
founders, we have attempted to overcome some of the
limitations of previous studies of this type. Considered in
combination with the ever-growing literature on sunlight,
vitamin D and cancer, the evidence is clear that exposure
to solar UV-B affords protection against numerous can-
cers, and that current public health recommendations that
Table 4: Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, 
non-Hispanic whites (95% CI in parentheses): Cancer sites with no evidence of an inverse association with solar UV-B exposure (see 
notes for Table 2).
Incidence Mortality
Cancer site Males Females Males Females
Liver and intrahepatic bile 
duct
1.01 (0.95–1.08) 1.05 (0.96–1.14) 0.88 (0.85–0.92) 0.85 (0.81–0.89)
Nose, nasal cavity, and 
inner ear
0.80 (0.68–0.95) 0.85 (0.71–1.03) 0.93 (0.76–1.13) 0.99 (0.80–1.23)
Larynx 0.87 (0.82–0.92) 0.80 (0.72–0.89) 1.04 (0.98–1.11) 0.96 (0.86–1.07)
Bone and joint 0.83 (0.69–1.01) 0.95 (0.78–1.17) 0.62 (0.54–0.72) 0.57 (0.49–0.66)
Soft tissue, including heart 0.84 (0.77–0.92) 0.94 (0.85–1.03) 1.10 (1.02–1.19) 1.23 (1.14–1.33)
Ovary 1.03 (0.99–1.06) 1.09 (1.06–1.11)
Brain and other nervous 
system
1.08 (1.02–1.14) 1.07 (1.01–1.14) 0.91 (0.87–0.94) 0.86 (0.83–0.90)
Thyroid (males) 1.05 (0.96–1.13) 1.00 (0.87–1.16)
Miscellaneous sites 0.83 (0.79–0.86) 0.93 (0.89–-0.97) 1.16 (1.13–1.18) 1.23 (1.20–1.26)
Table 5: Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, 
non-Hispanic whites (95% CI in parentheses): Cancer sites with evidence of an positive association with solar UV-B exposure (see notes 
for Table 2).
Incidence Mortality
Cancer site Males Females Males Females
Oral cavity and pharynx 0.77 (0.74–-0.80) 0.83 (0.79–0.88) 0.79 (0.76–0.83) 0.73 (0.69–0.77)
Anus, anal canal, and 
anorectum
0.68 (0.59–0.78) 0.71 (0.64–0.79) 0.69 (0.54–0.88) 0.67 (0.56–0.80)
Melanoma 0.72 (0.70–0.74) 0.78 (0.75–0.81) 0.70 (0.67–0.73) 0.83 (0.78–0.87)
Other non-epithelial skin 0.61 (0.55–0.67) 1.04 (0.92–1.18) 0.56 (0.52–0.61) 0.71 (0.63–0.79)
Cervix 0.84 (0.80–0.89) 0.89 (0.84–0.94)BMC Cancer 2006, 6:264 http://www.biomedcentral.com/1471-2407/6/264
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advocate little or no sunlight exposure should be revisited
– especially since the adverse health effects of vitamin D
deficiency are not limited to cancer, but also appear to
include type 1 diabetes, multiple sclerosis, rheumatoid
arthritis, cardiovascular disease, and osteoporosis [5].
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